SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-011219
Filing Date
2024-03-14
Accepted
2024-03-14 16:12:34
Documents
16
Period of Report
2024-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K intensity-20240314.htm   iXBRL 8-K 29606
2 EX-99.1 a20240314ex99120231231pres.htm EX-99.1 79953
6 image01.jpg GRAPHIC 4474
  Complete submission text file 0001628280-24-011219.txt   257996

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT intensity-20240314.xsd EX-101.SCH 1946
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT intensity-20240314_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT intensity-20240314_pre.xml EX-101.PRE 13606
17 EXTRACTED XBRL INSTANCE DOCUMENT intensity-20240314_htm.xml XML 2935
Mailing Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880
Business Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

IRS No.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41109 | Film No.: 24750261
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)